Cargando…
Scale-Up of Academic Mesenchymal Stromal Cell Production
Background: Many clinical trials have reported the use of mesenchymal stromal cells (MSCs) following the indication of severe SARS-CoV-2 infection. However, in the COVID19 pandemic context, academic laboratories had to adapt a production process to obtain MSCs in a very short time. Production proces...
Autores principales: | Laroye, Caroline, Gauthier, Mélanie, Morello, Jessica, Charif, Naceur, Cannard, Véronique Latger, Bonnet, Céline, Lozniewski, Alain, Tchirkov, Andrei, De Isla, Natalia, Decot, Véronique, Reppel, Loïc, Bensoussan, Danièle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342966/ https://www.ncbi.nlm.nih.gov/pubmed/37445448 http://dx.doi.org/10.3390/jcm12134414 |
Ejemplares similares
-
Mesenchymal Stem/Stromal Cell Production Compliant with Good Manufacturing Practice: Comparison between Bone Marrow, the Gold Standard Adult Source, and Wharton’s Jelly, an Extraembryonic Source
por: Laroye, Caroline, et al.
Publicado: (2019) -
Systematic Review on CAR-T Cell Clinical Trials Up to 2022: Academic Center Input
por: Wang, Valentine, et al.
Publicado: (2023) -
A French single-center experience on allogeneic stem cell transplant cryopreservation during severe acute respiratory syndrome coronavirus 2 pandemic
por: Laroye, Caroline, et al.
Publicado: (2023) -
Efficacy of Wharton Jelly Mesenchymal Stromal Cells infusions in moderate to severe SARS-Cov-2 related acute respiratory distress syndrome: a phase 2a double-blind randomized controlled trial
por: Pochon, Cécile, et al.
Publicado: (2023) -
Chondrogenic induction of mesenchymal stromal/stem cells from Wharton’s jelly embedded in alginate hydrogel and without added growth factor: an alternative stem cell source for cartilage tissue engineering
por: Reppel, Loïc, et al.
Publicado: (2015)